613 related articles for article (PubMed ID: 30822457)
1. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus.
Hasan M; Ghosh PP; Azim KF; Mukta S; Abir RA; Nahar J; Hasan Khan MM
Microb Pathog; 2019 May; 130():19-37. PubMed ID: 30822457
[TBL] [Abstract][Full Text] [Related]
2. Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirus.
Hasan M; Azim KF; Begum A; Khan NA; Shammi TS; Imran AS; Chowdhury IM; Urme SRA
Infect Genet Evol; 2019 Jun; 70():140-157. PubMed ID: 30849525
[TBL] [Abstract][Full Text] [Related]
3. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.
De Groot AS; Moise L; Liu R; Gutierrez AH; Terry F; Koita OA; Ross TM; Martin W
Hum Vaccin Immunother; 2014; 10(2):256-62. PubMed ID: 24525618
[TBL] [Abstract][Full Text] [Related]
4. Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus).
Azim KF; Hasan M; Hossain MN; Somana SR; Hoque SF; Bappy MNI; Chowdhury AT; Lasker T
Infect Genet Evol; 2019 Oct; 74():103936. PubMed ID: 31233780
[TBL] [Abstract][Full Text] [Related]
5. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9.
Tarrahimofrad H; Rahimnahal S; Zamani J; Jahangirian E; Aminzadeh S
Sci Rep; 2021 Dec; 11(1):24485. PubMed ID: 34966175
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatic based designing of potential immunogenic novel mRNA and peptide-based prophylactic vaccines against H5N1 and H7N9 avian influenza viruses.
Ghafoor D; Zeb A; Ali SS; Ali M; Akbar F; Ud Din Z; Ur Rehman S; Suleman M; Khan W
J Biomol Struct Dyn; 2024 Apr; 42(7):3641-3658. PubMed ID: 37222664
[TBL] [Abstract][Full Text] [Related]
7. Insight into the first multi-epitope-based peptide subunit vaccine against avian influenza A virus (H5N6): An immunoinformatics approach.
Mia MM; Hasan M; Ahmed S; Rahman MN
Infect Genet Evol; 2022 Oct; 104():105355. PubMed ID: 36007760
[TBL] [Abstract][Full Text] [Related]
8. Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.
To KK; Zhang AJ; Chan AS; Li C; Cai JP; Lau CC; Li CG; Jahan AS; Wu WL; Li L; Tsang AK; Chan KH; Chen H; Yuen KY
Arch Virol; 2015 Mar; 160(3):777-86. PubMed ID: 25616843
[TBL] [Abstract][Full Text] [Related]
9. Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study.
Jafari D; Malih S; Gomari MM; Safari M; Jafari R; Farajollahi MM
BMC Mol Cell Biol; 2020 Dec; 21(1):89. PubMed ID: 33276715
[TBL] [Abstract][Full Text] [Related]
10. An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin.
Song L; Xiong D; Kang X; Yang Y; Wang J; Guo Y; Xu H; Chen S; Peng D; Pan Z; Jiao X
BMC Biotechnol; 2015 Aug; 15():79. PubMed ID: 26286143
[TBL] [Abstract][Full Text] [Related]
11. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.
De Groot AS; Ardito M; Terry F; Levitz L; Ross T; Moise L; Martin W
Hum Vaccin Immunother; 2013 May; 9(5):950-6. PubMed ID: 23807079
[TBL] [Abstract][Full Text] [Related]
12. Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
Russo G; Crispino E; Maleki A; Di Salvatore V; Stanco F; Pappalardo F
BMC Bioinformatics; 2023 Jun; 24(1):231. PubMed ID: 37271819
[TBL] [Abstract][Full Text] [Related]
13. T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
Moise L; M Biron B; Boyle CM; Kurt Yilmaz N; Jang H; Schiffer C; M Ross T; Martin WD; De Groot AS
Hum Vaccin Immunother; 2018; 14(9):2203-2207. PubMed ID: 30015562
[TBL] [Abstract][Full Text] [Related]
14. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
Jalal K; Khan K; Uddin R
Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
[TBL] [Abstract][Full Text] [Related]
15. Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.
Chen WA; Zhang J; Hall KM; Martin CB; Kisselev S; Dasen EJ; Vahanian NN; Link CJ; Martin BK
PLoS One; 2017; 12(8):e0182683. PubMed ID: 28787006
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
[TBL] [Abstract][Full Text] [Related]
17. Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.
Shahsavandi S; Ebrahimi MM; Sadeghi K; Mahravani H
Virol Sin; 2015 Jun; 30(3):200-7. PubMed ID: 25894902
[TBL] [Abstract][Full Text] [Related]
18. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.
Rudenko L; Isakova-Sivak I; Donina S
Vaccine; 2013 Oct; 31(42):4702-5. PubMed ID: 23988294
[TBL] [Abstract][Full Text] [Related]
19. Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus.
Sharma S; Kumari V; Kumbhar BV; Mukherjee A; Pandey R; Kondabagil K
Immunobiology; 2021 Mar; 226(2):152053. PubMed ID: 33517154
[TBL] [Abstract][Full Text] [Related]
20. Design of multi-epitope based vaccine against
Nayak SS; Sethi G; Ramadas K
J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
